• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Wound Care

Organogenesis launches new sizing option for PuraPly wound care device

March 15, 2018 By Sarah Faulkner

Organogenesis acquires NuTech Medical

MIT-spinoff Organogenesis announced today that its PuraPly antimicrobial wound care device is now available in a 1.6-cm disc size. The Canton, Mass.-based company’s PuraPly AM product includes a broad-spectrum antibiotic, polyhexamethylene biguanide, embedded into a purified native collagen matrix. The device is cleared to treat an array of wound types, including pressure ulcers, surgical wounds, trauma wounds […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wound Care Tagged With: Organogenesis

Ex-Advanced BioHealing exec draws probation in VA fraud case

February 12, 2018 By Brad Perriello

Advanced BioHealing

A former Advanced BioHealing executive who admitted to federal charges that he bribed U.S. Veterans Affairs Dept. doctors to use the company’s DermaGraft biologic wound dressing last week drew probation in the case. Federal had prosecutors accused Todd Clawson, who left the company in 2012, of participating in a scheme to bribe VA physicians to use the DermaGraft diabetic […]

Filed Under: Featured, Legal News, Regenerative Medicine, Wound Care Tagged With: Advanced BioHealing, Shire

Pertinax Pharma tackles wound care, dental health and more with its controlled-release antiseptic

November 3, 2017 By Sarah Faulkner

Pertinax Pharma

For nearly a decade, Michele Barbour and her team of researchers at the University of Bristol have been developing controlled-release salts of a commonly-used chemical called chlorhexidine. Barbour believed her technology had enormous potential – so she decided to start a company. “When you’re an academic, you have a lot of freedom but you also […]

Filed Under: Featured, Pharmaceuticals, Wound Care Tagged With: pertinaxpharma

MediWound raises $25m

October 27, 2017 By Fink Densford

MediWound touts Phase II study

MediWound (NSDQ:MDWD) today announced a $25.2 million offering to support research and development of its EscharEx topical biological drug for debridement of chronic and other hard-to-heal wounds. In the offering, the Israel-based company floated approximately 5 million shares, including 637,664 shares through an underwriter’s option, according to an SEC filing. Cowen & Company and Wells Fargo […]

Filed Under: Business/Financial News, Pharmaceuticals, Wound Care Tagged With: MediWound

Meet the two former Johns Hopkins residents disrupting the wound care market

October 20, 2017 By Sarah Faulkner

Ned Swanson and Denver Lough were plastic surgery residents at Johns Hopkins when they made a choice that would change the course of their lives – they decided to drop out and start a business. Lough had a technology that they thought could help patients if it ever made it to the market, but their […]

Filed Under: Featured, Wall Street Beat, Wound Care Tagged With: polarityte

The 11 most innovative medical devices of 2017

October 19, 2017 By Danielle Kirsh

The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for the […]

Filed Under: Cardiovascular, Diabetes, Diagnostics, Featured, Hematology, Hospital Care, Imaging, Neurological, Oncology, Patient Monitoring, Research & Development, Surgical, Wound Care Tagged With: abbott, Allergan, Biosense Webster, Boston Scientific, BrainScope, DePuy Synthes, Ethicon, INSIGHTEC, Integra LifeSciences, johnsonandjohnson, Koning Corporation, medtech

Avita Medical aims for $13m to bring ReCell burn injury device to U.S.

October 11, 2017 By Sarah Faulkner

Avita Medical

Avita Medical (ASX:AVH) said today that it hopes to raise $13.2 million to fund its efforts to bring its ReCell autologous cell harvesting device for treatment of burn injuries to the U.S. The Australia-based company said it received commitments from investors for a $3.5 million private placement. Avita added that it plans to undertake a rights […]

Filed Under: Featured, Funding Roundup, Regenerative Medicine, Wall Street Beat, Wound Care Tagged With: avitamedical

Smart bandage releases medication as needed

October 10, 2017 By Sarah Faulkner

Smart bandage

A team of researchers from the University of Nebraska, Harvard Medical School and MIT have created a smart bandage that can be loaded with antibiotics, painkillers or other drugs and triggered by a smartphone. The bandage, made of electrically conductive fibers individually coated in a drug-loaded hydrogel, could be used to deliver multiple drugs at […]

Filed Under: Drug-Device Combinations, Featured, Regenerative Medicine, Research & Development, Wound Care Tagged With: Harvard University, Massachusetts Institute of Technology, universityofnebraska

FDA expands protocol for investigational ReCell burn injury device

October 4, 2017 By Sarah Faulkner

Avita Medical

Avita Medical (ASX:AVH) said today that the FDA approved a supplement to the company’s investigational device exemption for its ReCell autologous cell harvesting device. The approved treatment protocol for burn injuries has been simplified, according to the company, and the number of approved investigational sites has grown from eight to 15. Up until now, treatment using […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regenerative Medicine, Wall Street Beat, Wound Care Tagged With: avitamedical

Avita Medical submits PMA app for ReCell burn injury treatment

September 28, 2017 By Sarah Faulkner

Avita Medical

Avita Medical (ASX:AVH) said today that it submitted its pre-market approval application to the FDA for its ReCell autologous cell harvesting device. The company’s system is designed to reduce the amount of skin harvesting needed to treat burn injuries compared to conventional treatments. The PMA application is supported by clinical data from two trials. The […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Regenerative Medicine, Wound Care Tagged With: avitamedical

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS